The tumor marker carcinoembryonic antigen (CEA) was generally increased, as were alkaline phosphatase (ALP), creatinine, and C-reactive protein (CRP), in patients with colorectal adenocarcinoma. This evidence concerns the gene CEACAM5 and colorectal adenocarcinoma.